We associated four key immune checkpoint inhibitor genes (PDCD1, CD274, PDCD1LG2, CTLA-4, HAVCR2, and IDO1) and 25 immune checkpoint-related genes with risk scores with revealing the potential therapeutic targets in the treatment of COAD. Here, PDCD1 is linked to colon adenocarcinoma.